jorge L.
- Country
- Spain
- Department
- Clinical Haematology
Research Overview
- Efficacy and Safety of Oral Decitabine and Ivosidenib in Adults with Newly Diagnosed IDH1-Mutated Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy
- Phase 3 Study of Quizartinib with Chemotherapy in FLT3-ITD Negative Acute Myeloid Leukemia Patients
- A Multicenter Randomized Trial Comparing Fosfomycin Calcium and Ciprofloxacin Hydrochloride for Febrile Neutropenia in Acute Leukemia Patients
Data & Insights
Has run more than one trial at 54 of 170 partner sites.
Specializations
Hematologic Oncology
The investigator specializes in the treatment of acute myeloid leukemia (AML), with particular emphasis on developing innovative therapeutic approaches for newly diagnosed patients.
- Blood Cancer Treatment
- Leukemia Management
- Hematologic Malignancies
Their research focus includes exploring targeted therapies for AML patients, particularly those without specific genetic mutations.
Therapeutic Development
The investigator's work centers on evaluating novel therapeutic combinations including targeted agents with standard chemotherapy for blood cancer treatment.
- Combination Therapy
- Treatment Innovation
- Maintenance Therapy
Their expertise extends to developing treatment protocols that incorporate both induction and consolidation approaches.
Clinical Outcomes
The investigator focuses on assessing overall survival outcomes in hematologic malignancy treatments, particularly in the context of newly diagnosed patients.
- Survival Analysis
- Treatment Efficacy
- Patient Response
Their research encompasses long-term therapeutic strategies including extended maintenance treatment approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.